Copper nanocluster-MoS2 fluorescence sensor, preparation method thereof and application of copper nanocluster-MoS2 fluorescence sensor in rapid detection of myocardial infarction
Through the copper nanocluster-MoS2 fluorescence sensor combined with the FRET effect, the problems of slow detection speed and low sensitivity in the early diagnosis of myocardial infarction are solved, and the rapid and sensitive detection of miRNA-208a is achieved, which is suitable for the early diagnosis and treatment of myocardial infarction. monitor.
Patent Information
- Application Number
- CN202411048304.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-19
AI Technical Summary
The existing early diagnosis methods for myocardial infarction have problems with slow detection speed and low sensitivity, especially in the rapid detection of miRNA-208a, which is difficult to meet the needs in emergencies.
Using copper nanocluster-MoS2 fluorescence sensor, copper nanoclusters were combined with MoS2 nanosheets through preparation method, and the FRET effect was used to achieve rapid and sensitive detection of miRNA-208a, including copper salts, branched polyethyleneimine and Ascorbic acid reaction generates PEI@CuNCs, which are then bound to MoS2 nanosheets and cDNA to form a fluorescence sensor, and miRNA-208a is detected by monitoring fluorescence intensity changes.
A high sensitivity detection of miRNA-208a is achieved, with a detection limit of up to 0.9nM. It can quickly detect serum within 20 minutes and detect miRNA-208a in plasma within 5 minutes. It has high specificity and efficiency, and is suitable for myocardial muscles. Early diagnosis of infarction.
Smart Images

Figure CN118978911A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biochemical engineering, and specifically relates to copper nanoclusters-MoS 2 Fluorescent sensor, preparation method thereof and application in rapid detection of myocardial infarction. Background Art
[0002] Acute myocardial infarction (AMI) is a serious cardiovascular disease. About 17 million people die from cardiovascular disease each year, of which about half are caused by AMI, which is one of the main diseases that endanger people's health. In 2025, cardiovascular disease is expected to become the leading cause of death worldwide, accounting for 32% of all deaths worldwide. Therefore, early diagnosis of acute myocardial infarction is of great significance to the patient's life safety, improving prognosis, preventing disease deterioration, and improving quality of life.
[0003] MicroRNAs (miRNA) are endogenous genes that encode non-coding single-stranded RNA molecules with a length of about 22 nucleotides. They have important biological functions in gene expression regulation, cell differentiation, and the occurrence and development of diseases. Studies have shown that miRNA plays an important role in the pathogenesis of AMI through a variety of cellular processes, including cardiomyocyte proliferation, apoptosis, survival regeneration, and autophagy. Therefore, targeted miRNA rapid detection may have important clinical significance for the treatment of AMI patients. After myocardial infarction, miRNAs such as miRNA-1, miRNA-208a, miRNA-133a, miRNA-499, and miRNA-24 are significantly increased in the early stage. Among them, miRNA-208a is a cardiac-specific miRNA that is highly expressed in cardiomyocytes and only works in cardiac tissue, not in other organs and tissues. MiRNA-208a may be a potential biomarker and therapeutic target for AMI. Compared with troponin, miRNA-208a appears earlier and is detected faster. Therefore, achieving high sensitivity and specificity in miRNA-208a detection is of great significance for the early diagnosis, treatment monitoring, and prognosis evaluation of myocardial infarction, and can minimize the disability and mortality rates.
[0004] FRET detection of miRNA has the advantages of strong anti-interference ability, high accuracy and good repeatability. Subsequently, based on the FRET effect, the fluorescence system has been further developed by integrating several nanomaterials to construct fluorescence sensors. The interaction of these nanomaterials is converted into changes in fluorescence wavelength and intensity, making fluorescence sensors an excellent platform for cancer diagnosis and nucleic acid sensing.
[0005] In recent years, a variety of biosensors for detecting miRNA have been reported, among which metal nanocluster-mediated biosensors have attracted much attention. Compared with traditional organic dyes and semiconductor quantum dots, metal nanoclusters (NCs) have attracted extensive attention due to their ultra-small size, high fluorescence, low biotoxicity, and large Stokes shift. In particular, copper nanoclusters have the advantages of low cost, good fluorescence performance, high stability, and easy preparation, and can be used as excellent donors for fluorescent biosensors.
[0006] Single-layer / few-layer MoS 2 As a new type of material, nanomaterials have attracted widespread attention in the fields of industrial lubrication, biosensors, field effect transistors, photovoltaic and optoelectronic devices. 2 As a two-dimensional transition metal dichalcogenide (TMDs), nanosheets are highly efficient natural photoluminescence quenchers. Because they have obvious absorption from visible light to near-infrared regions, their quenching effect on fluorescent molecules is better than that on organic fluorescent molecules. 2 Nanosheets can adsorb DNA through non-covalent means such as van der Waals forces. 2 The nanosheets have a large specific surface area and can provide additional quenching sites, thus exhibiting a significant fluorescence quenching effect. Summary of the invention
[0007] The technical problem solved by the present invention is to provide a copper nanocluster-MoS2 fluorescent sensor and a preparation method thereof and application thereof in rapid detection of myocardial infarction.
[0008] The present invention first provides a copper nanocluster-MoS 2 The preparation method of the fluorescent sensor comprises the following steps:
[0009] Step 1: Dissolve copper salt and branched polyethyleneimine in water, add acetic acid to adjust the pH to 5.0, then add ascorbic acid, and stir the reaction at 60-150°C to obtain PEI@CuNCs;
[0010] Step 2: Dissolve ammonium molybdate and thiourea in water, perform hydrothermal reaction at 180-220°C for 12-24h, collect the product by centrifugation, wash and dry to obtain MoS 2 Nanosheets;
[0011] Step 3: Add cDNA to the buffer, then add PEI@CuNCs, and then add MoS 2 Copper nanoclusters-MoS prepared from nanosheet solution 2 Fluorescence sensor.
[0012] In step 1, PEI and Cu 2+ The molar ratio is 1:1-1:64, preferably 1:16;
[0013] Step 1 Cu 2+ The molar ratio of ascorbic acid is 25:(1-2); preferably 25:1.5;
[0014] The reaction temperature in step 1 is preferably 90°C;
[0015] In step 1, the copper salt is copper sulfate;
[0016] The stirring reaction time in step 1 is 1-4h, preferably 2h;
[0017] The hydrothermal reaction conditions in step 2 are preferably 200° C. for 18 h;
[0018] In step 3, the buffer is Tris-HCl;
[0019] In step 3, the concentration of cDNA in the fluorescent sensor is 0.05-5 μM, preferably 2 μM;
[0020] In step 3, the concentration of PEI@CuNCs in the fluorescent sensor is 3.9-500 μg / ml, preferably 20 μg / ml;
[0021] In step 3, the concentration of MoS2 nanosheets in the fluorescence sensor is 1-28 μg / ml, preferably 12 μg / ml.
[0022] The present invention also provides a method for detecting serum biomarker miRNA-208a of myocardial infarction using the fluorescent sensor prepared above, comprising the following steps: incubating the fluorescent sensor for 1-5 minutes, then introducing the target miRNA-208a into the mixture and hybridizing with cDNA for 15-25 minutes, and detecting miRNA-208a by monitoring the fluorescence intensity of the mixture before and after the introduction of miRNA-208a into the sensor.
[0023] The incubation time is preferably 1 min, and the hybridization time is preferably 20 min.
[0024] The present invention also provides a method for detecting the serum biomarker miRNA-208a of myocardial infarction using the fluorescent sensor prepared above, comprising the following steps: incubating the fluorescent sensor with the patient's plasma for 1-7 minutes and then detecting, preferably the detection time is 5 minutes, and the plasma is plasma to which anti-RNase is added.
[0025] The present invention introduces a single-stranded cDNA complementary to miRNA-208a into the PEI@CuNCs solution. Since PEI has an affinity for DNA, the single-stranded cDNA can be connected to the branch of PEI to form a PEI@CuNCs-DNA probe. 2 Nanosheets are introduced into the solution. DNA bases and MoS 2Due to the van der Waals force between the two planes, PEI@CuNCs-DNA is adsorbed on the MoS 2 Nanosheet surface. MoS 2 The nanosheet quenches the blue-green fluorescence of PEI@CuNCs-DNA through the FRET effect. Then, the target miRNA is introduced into the sensor, and the target miRNA hybridizes with cDNA to form a DNA-miRNA duplex. The complementary bases are buried by the helical phosphate backbone, resulting in the duplex formed with MoS 2 The interaction between them becomes so weak that the duplex is separated from MoS 2 The surface is thus removed. Thus, the original MoS 2 The nanosheets quenched the fluorescence of PEI@CuNCs bound to cDNA. Therefore, miRNA can be detected by monitoring the fluorescence switch and fluorescence intensity of the sensor.
[0026] The invention discloses a copper nanocluster-MoS 2 A fluorescent sensor for detecting serum biomarkers of myocardial infarction. The present invention optimizes the experimental conditions to obtain the best miRNA-208a detection performance. The results show that the sensor has a high detection sensitivity for miRNA-208a, and the detection limit can reach 0.9nM. In addition, the sensor can specifically recognize and bind to complementary miRNA-208a. The method can quickly detect miRNA-208a within 20 minutes and quickly detect miRNA-208a in patient plasma test specimens within 5 minutes. The sensor of the present invention has high sensitivity, specificity and efficiency, and is suitable for the detection of miRNA-208a. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 a is the Fourier transform infrared spectrum of PEI@CuNCs; Figure 1 b is the fluorescence spectrum of PEI@CuNCs; Figure 1 c is the UV absorption graph of PEI@CuNCs; Figure 1 d is the SEM and TEM images of PEI@CuNCs.
[0028] Figure 2 a is MoS 2 AFM image of MoS 2 UV-visible spectrum of c.MoS 2 XPS image of MoS 2 Mo3d and S2p peak fitting diagram.
[0029] Figure 3 Storage stability of PEI@CuNCs.
[0030] Figure 4 For different PEI and Cu 2+ The relative fluorescence activity of the molar ratio.
[0031] Figure 5 For cDNA-CuNCs probe, cDNA-CuNCs+MoS 2 , fluorescence emission spectra of cDNA-CuNCs+MoS2+miR-208a under different conditions.
[0032] Figure 6 is the fluorescence intensity of the sensor at different PEI@CuNCs concentrations. Figure 6 b is Figure 6 Partially enlarged view of a.
[0033] Figure 7 is the relative fluorescence intensity with different MoS 2 Variation of nanosheet concentration.
[0034] Figure 8 The fluorescence intensity in the sensor solution changes with the incubation time and hybridization time.
[0035] Fig. 9 a is the incubation of MoS with 10 nm single-base mismatch miRNA (SBM), double-base mismatch miRNA (DBM), mismatch sequence (MS) and miRNA-208a. 2 Fluorescence spectra of the fluorescent sensor; b. MoS after incubation with 10 nm single-base mismatch miRNA (SBM), double-base mismatch miRNA (DBM), mismatch sequence (MS) and miRNA-208a (△F=F-F0). 2 Relative fluorescence intensity of the fluorescent sensor. F0 and F are the fluorescence intensities before and after the introduction of miRNA into the sensor solution.
[0036] Fig.10 a is the fluorescence spectra of miRNA-208a at different concentrations; b is the curve and linear calibration relationship between the relative fluorescence intensity (△F=F-F0) and a series of miRNA-208A concentrations, where F0 and F are the fluorescence intensities of target miRNA-208a before and after being introduced into the sensor solution.
[0037] Fig.11 a. Plasma fluorescence test results of three patients with myocardial infarction; b. Changes in fluorescence values at different times in the plasma of AMI patients with anti-RNase added. DETAILED DESCRIPTION
[0038] The preferred embodiments of the present invention are described below in conjunction with the accompanying drawings. It should be understood that the preferred embodiments described herein are only used to illustrate and explain the present invention, and are not used to limit the present invention.
[0039] Example 1
[0040] A copper nanocluster-MoS 2 The preparation method of the fluorescent sensor comprises the following steps:
[0041] Add 100 μL 100 mM CuSO 4 , 50 μL 12.5 mM PEI (MW = 1800, 99%) and 5 mL pure water were fully mixed and stirred for 10 minutes. Then, the pH was adjusted to 5.0 with HAC, and 150 μL 4 mM ascorbic acid AA was added. Then, it was stirred at 90 ° C for 2 h to obtain PEI@CuNCs.
[0042] The sample mixture was purified by dialyzing in deionized water for 24 h using a 3500Da dialysis membrane to remove unreacted precursors and small molecular weight byproducts. The synthesized PEI@CuNCs showed stable blue-green fluorescence under UV light and maintained its spectral characteristics even when stored at 4°C for at least two months.
[0043] Use an electronic balance to weigh 2.24g (1mmol) of ammonium molybdate and 2.13g (28mmol) of thiourea, add 35ml of deionized water, and then stir magnetically for about 30 minutes to completely dissolve it to obtain a uniformly mixed solution. The above solution was transferred to a 50ml polytetrafluoroethylene hydrothermal reactor, sealed, and placed in a 200℃ constant temperature drying oven for 18h. After the reaction was completed, the reactor was left to cool at room temperature and the reaction product was collected by centrifugation. The product was transferred to a centrifuge tube, centrifuged at 8500 rpm for 10min, and the supernatant was removed. The remaining black precipitate was repeatedly washed with deionized water and anhydrous ethanol until neutral, and then vacuum dried at 60℃ for 12h to obtain MoS 2 Nanosheets.
[0044] cDNA (50ul) was introduced into 20mM Tris-HCl buffer (150mM NaCl, pH7.6, 940ul). Then PEI@CuNCs (50μl) was added to the cDNA solution. After the reaction was completed, MoS 2 The fluorescent sensor was prepared from the nanosheet solution (10 μl). The concentration of cDNA in the fluorescent sensor was 2 μM, the concentration of PEI@CuNCs was 20 μg / ml, and the concentration of MoS 2 The concentration of nanosheets was 12 μg / ml.
[0045] The performance of PEI@CuNCs was characterized, such as Figure 1 shown. Figure 1 a is the Fourier transform infrared spectrum of PEI@CuNCs, in which the characteristic absorption peak of amino group appears at 3424 cm -1 and 1650cm-1 It can be confirmed that PEI@CuNCs were synthesized by chemical reduction. The fluorescence spectrum of PEI@CuNCs is shown in Figure 1 b, the UV absorption diagram is as follows Figure 1 c. The excitation and emission wavelengths of PEI@CuNCs are 370 and 490 nm, respectively, and the Stokes shift is 120 nm, indicating that the synthesized copper nanoclusters have good fluorescence properties. In addition, the PEI@CuNCs solution is brown under visible light and exhibits blue-green fluorescence under ultraviolet light (365 nm). The morphology of PEI@CuNCs was characterized by SEM and TEM. Figure 1 d shows that the average diameter of the prepared PEI@CuNCs is about 50 nm.
[0046] The prepared MoS 2 To characterize performance, such as Figure 2 shown. Figure 2 a is MoS 2 Atomic force microscope image of the nanosheet; it can be seen that MoS 2 The nanosheets are two-dimensional thin nanosheets with lateral dimensions of 400-900 nm and a thickness of 3.42 nm, indicating that MoS 2 Fewer layers. Figure 2 b is MoS 2 UV-visible spectra of nanosheet dispersions, MoS 2 The aqueous dispersion of the nanosheets is dark brown, and the UV-visible absorption band is between 300 and 600 nm. Figure 2 c is MoS 2 Full spectrum of nanosheets; Figure 2 d is MoS 2 Mo 3d and S2p peak fitting diagram of nanosheets. MoS 2 The XPS images of nanomaterials, Mo 3d and S2p peak fitting diagrams show that MoS 2 The elemental composition of the quartz crystal is Mo and S, which can be obtained by searching the XPS element binding energy table. The two peaks at 229.78 eV and 232.88 eV correspond to MoS 2 Mo3d 3 / 2 and Mo3d 5 / 2 , the two peaks at 162.58 eV and 163.83 eV correspond to MoS 2 S2p 1 / 2 and S2p 3 / 2 It can be seen that the present application prepared MoS 2 Nanosheets.
[0047] In addition, the stability of PEI@CuNCs was tested. The prepared PEI@CuNCs were stored in a refrigerator, and then the PEI@CuNCs stored for different times were dispersed in a pure aqueous solution. The fluorescence emission intensity at an emission wavelength of 490 nm was measured. The results are as follows: Figure 3 As shown in the figure, it can be seen that the fluorescence intensity of PEI@CuNCs does not decrease significantly after being stored for 2 months, and still shows good fluorescence properties. This shows that the fluorescence performance of PEI@CuNCs prepared by the present invention is relatively stable.
[0048] Example 2
[0049] In Example 1, PEI and Cu 2+ The molar ratio of PEI to Cu was 1:16, and the concentration of PEI was changed to change the 2+ The molar ratios were 10:1, 5:1, 2:1, 1:1, 1:2, 1:4, 1:8, 1:32, and 1:64, respectively, and the relative fluorescence intensity of PEI@CuNCs was tested. The results are shown in Figure 4 As shown in the figure, it can be seen that PEI and Cu 2+ The molar ratio of PEI to Cu was 1:16, and the relative fluorescence intensity reached 2200%. 2+ The performance is poor when the molar ratio is lower than 10:1, 5:1, and 2:1, so it is not selected in the present invention.
[0050] Example 3
[0051] The stirring reaction time for preparing PEI@CuNCs was adjusted to 0.5h, 1h, 3h, 4h, and 5h, and compared with 2h in Example 1, and the rest was the same as Example 1. The relative fluorescence intensity of PEI@CuNCs was tested, and the results showed that the relative fluorescence was low when the stirring reaction time was 0.5h and 5h, both below 500%, so it was not selected in the present invention. The relative fluorescence intensity at the reaction time of 1h, 2h, 3h, and 4h first increased and then decreased, reaching the maximum value at 2h.
[0052] Example 4
[0053] The Cu content was adjusted by adjusting the amount of ascorbic acid. 2+ The molar ratio of ascorbic acid to ascorbic acid, the amount of ascorbic acid was adjusted to 0, 25 μL, 50 μL, 100 μL, 200 μL, 250 μL, and the rest was the same as Example 1. The relative fluorescence intensity of PEI@CuNCs was tested, and the results showed that when the amount of ascorbic acid was below 50 μL and 250 μL, the relative fluorescence intensity was below 500%, so it was not selected in the present invention. When the amount was 100 μL, and 150 μL and 200 μL in Example 1, the relative fluorescence intensity first increased and then decreased, reaching a maximum value at 150 μL.
[0054] Example 5
[0055] A method for detecting serum biomarker miRNA-208a of myocardial infarction comprises the following steps: incubating the fluorescent sensor prepared in Example 1 for 1 min, adsorbing cDNA-PEI@CuNCs on MoS 2 The target miRNA-208a was then introduced into the mixture to hybridize with cDNA for 20 min. The miRNA-208a was detected by monitoring the fluorescence intensity of the mixture before and after the introduction of miRNA-208a into the sensor.
[0056] The fluorescence signal was detected by a four-way quartz tube (10 mm) fluorescence spectrometer. The excitation and emission wavelengths were 370 nm and 490 nm, respectively, the test range was 380-700 nm, the excitation light bandwidth was 10 nm, and the emission light bandwidth was 10 nm.
[0057] The cDNA-CuNCs probe, cDNA-CuNCs+MoS 2 、cDNA-CuNCs+MoS 2 + Fluorescence emission spectra of miR-208a under different conditions. The results are as follows Figure 5 a. And the Zeta potential was tested, as shown in Figure 5 As shown in b. Figure 5 As can be seen in a: First, the fluorescence signal of the cDNA-PEI@CuNCs solution was measured. Due to the fluorescence of the copper nanoclusters, the solution should show a higher fluorescence intensity. Secondly, MoS 2 , due to MoS 2 It can adsorb single-stranded cDNA, quenching the fluorescence and reducing the fluorescence intensity. Third, the target miRNA-208a is added to the sensor solution and adsorbed on MoS 2 cDNA hybridization on the surface of nanosheets. The hybridized cDNA-miRNA-208a duplex leaves MoS 2 The fluorescence should be restored after the surface is removed. The change in fluorescence signal is consistent with expectations. Since PEI contains a large number of amino groups, they exhibit high cationic charge intensity, which helps to bind to the negatively charged MoS 2 Electrostatic attraction interaction of nanosheets. After incubating PEI@CuNCs with nanosheets, CuNCs are easily adsorbed on the surface of nanosheets. Zeta potential was used to measure the electrostatic attraction between CuNCs and MoS 2 The surface charge of the nanosheet. Figure 4 As shown in b, with the addition of CuNCs, cDNA-CuNCs-MoS 2The surface potential of the composite changed significantly from -65.15 mV to 114.9 mV, indicating that CuNCs adsorbed positively charged CuNCs, confirming the interaction between CuNCs and MoS 2 This indicates that the present invention successfully constructed PEI@CuNCS-MoS for miRNA-208a detection. 2 sensor.
[0058] Example 6
[0059] Based on Example 1, the concentration of PEI@CuNCs solution in the sensor was adjusted (MoS 2 The concentration of the nanosheet solution is 0), and the fluorescence value of the fluorescence sensor before and after the addition is tested. The results are as follows Figure 6 As shown. With the increase of PEI@CuNCs concentration, the fluorescence gradually increases. According to the fluorescence conditions, the optimal fluorescence value is between 200-400nm. When the concentration of PEI@CuNCs is too high, the fluorescence value is too high and it is not easy to be quenched. Therefore, the concentration corresponding to the intermediate light intensity of 20μg / ml is preferred for subsequent experiments.
[0060] Based on Example 1, the concentration of PEI@CuNCs solution in the sensor was fixed at 20 μg / ml, and the concentration of MoS 2 The fluorescence intensity of the nanosheets before and after the concentration test is recorded as F0 and F. The results are shown in Figure 7 As shown, when MoS 2 When the concentration increased from 1 μg / ml to 12 μg / ml, the ΔF value increased significantly. 2 When the concentration is higher than 12 μg / ml, the ΔF value begins to decrease. 2 The optimal concentration was 12 μg / ml.
[0061] Example 7
[0062] The incubation time in Example 5 was adjusted and the fluorescence intensity was tested. Figure 8 The fluorescence intensity decreases rapidly and reaches equilibrium within only 1 min. This indicates that MoS 2 The nanosheets can quench the fluorescence of CuNCs within 1 min, thus converting MoS 2 The incubation time for introducing the sensor solution was set to 1 min. The green curve is the fluorescence signal when the target miRNA-208a was introduced into the sensor solution for hybridization. The fluorescence intensity recovered slowly at first, then recovered rapidly, and reached the maximum fluorescence value in 20 minutes. Therefore, the detection time of this experiment was selected as 20 minutes.
[0063] Example 8
[0064] The method of hybridization of single-base mismatch miRNA (SBM), double-base mismatch miRNA (DBM), mismatch sequence (MS) and complementary miRNA-208a with DNA probe was introduced into the fluorescence sensor detection to evaluate the MoS 2 The sensor detects the specificity of miRNA-208a. The specific experimental method is the same as that of Example 5, except that miRNA-208a is replaced by single-base mismatch miRNA (SBM), double-base mismatch miRNA (DBM), and mismatch sequence (MS).
[0065] Fig. 9 The fluorescence signal of the sensor after 20 minutes of hybridization of 4 different sequences (10nM) is shown. The fluorescence reaction caused by complementary miRNA-208a is higher than that of the other three. According to the formula, the MS concentration is close to 0, and the DBM and SBM concentrations are 0.72nm and 0.36nm, respectively, which are much lower than their actual concentrations, indicating that sequence mismatches cannot trigger the sensor to produce obvious fluorescence signals. The detection value of the sensor for miRNA-208a is 9.43nm, which is close to the actual concentration, indicating that the sensor has good selectivity. The main reason is the specific reaction of the cDNA probe with miRNA-208A.
[0066] Example 9
[0067] Under the above optimal experimental conditions, the sensitivity of the sensor based on cDNA-PEI@CuNCs to detect miRNA-208a was studied. The specific experimental method was the same as that in Example 5, and different concentrations of target miRNA-208a were added to hybridize with the DNA probe of the sensor. Fig.10 a shows a series of fluorescence changes of miRNA-208a concentrations (0-100 nM).
[0068] As the concentration of miRNA-208a increases, the fluorescence intensity increases significantly. The linear calibration relationship between the relative fluorescence intensity and concentration of the miRNA-208a series is shown in Fig.10 As shown in b. Within the concentration range of miRNA-208a, the change in the fluorescence intensity of the sensor showed a good linear relationship with the concentration of miRNA-208a. The linear equation was y = 23.38x + 3.46, r 2 = 0.9965. The sensor detection limit calculated based on the 3σ method was 0.9 nM.
[0069] Example 10
[0070] On the basis of Example 5, miRNA-208a was replaced with patient plasma to test the sensitivity of the cDNA-PEI@CuNCs-based sensor to patient plasma detection. Fig.11a shows the plasma fluorescence intensity values of three patients. According to the linear equation, the miRNA-208a content of the patients was 4.1 nM, 4.2 nM, and 6.1 nM. Fig.11 b shows that the fluorescence intensity reaches stability within 5 min after the addition of anti-RNase. Therefore, the cDNA-PEI@CuNCs-based fluorescence sensor is suitable for high-sensitivity detection of miRNA-208a and has potential application value in the diagnosis of myocardial infarction.
[0071] The principles, steps, etc. not explicitly described in the present invention are all obtainable by those skilled in the art through conventional technical means, and therefore will not be described in detail. Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A method for preparing a copper nanocluster-MoS2 fluorescence sensor, characterized in that: The following steps are involved: Step 1: Dissolve copper salt and branched polyethyleneimine in water, add acetic acid to adjust the pH to 5.0, then add ascorbic acid, and stir the reaction at 60-150°C to obtain PEI@CuNCs; Step 2: Dissolve ammonium molybdate and thiourea in water, perform hydrothermal reaction at 180-220°C for 12-24h, collect the product by centrifugation, wash and dry to obtain MoS2 nanosheets; Step 3: Add cDNA to the buffer, then add PEI@CuNCs, and then add MoS2 nanosheet solution to prepare the copper nanocluster-MoS2 fluorescent sensor.
2. The method for preparing a copper nanocluster-MoS2 fluorescence sensor according to claim 1, characterized in that: In step 1, PEI and Cu 2+ The molar ratio is 1:1-1:64; The reaction temperature in step 1 is preferably 90°C; In step 1, the copper salt is copper sulfate.
3. The method for preparing a copper nanocluster-MoS2 fluorescence sensor according to claim 1 or 2, characterized in that: In step 1, PEI and Cu 2+ The molar ratio is 1:
16.
4. The method for preparing a copper nanocluster-MoS2 fluorescence sensor according to claim 1, characterized in that: The hydrothermal reaction conditions in step 2 are preferably 200° C. for 18 h.
5. The method for preparing a copper nanocluster-MoS2 fluorescence sensor according to claim 1, characterized in that: The concentration of cDNA in the fluorescence sensor in step 3 is 0.05-5 μM; the concentration of PEI@CuNCs in the fluorescence sensor in step 3 is 9-500 μg / ml; the concentration of MoS2 nanosheets in the fluorescence sensor in step 3 is 1-28 μg / ml.
6. The copper nanocluster-MoS2 fluorescence sensor prepared according to the preparation method according to any one of claims 1 to 5.
7. A method for detecting serum biomarker miRNA-208a for myocardial infarction, characterized in that: The method comprises the following steps: incubating the copper nanocluster-MoS2 fluorescent sensor described in claim 6 for 1-5 minutes, then introducing the target miRNA-208a into the mixture and hybridizing with cDNA for 15-25 minutes, and detecting miRNA-208a by monitoring the fluorescence intensity of the mixture before and after the introduction of miRNA-208a into the sensor.
8. The method for detecting serum biomarker miRNA-208a of myocardial infarction according to claim 7, characterized in that: The incubation time was 1 min and the hybridization time was 20 min.
9. A method for detecting serum biomarker miRNA-208a for myocardial infarction, characterized in that: The method comprises the following steps: incubating the copper nanocluster-MoS2 fluorescent sensor described in claim 6 with patient plasma for 1-7 minutes and then conducting detection.
10. The method for detecting serum biomarker miRNA-208a of myocardial infarction according to claim 9, characterized in that: The incubation time was 5 min, and the plasma was plasma to which anti-RNase was added.
